Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haarer

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Cell Reports|September 23, 2020
Replication Stress Induces Global Chromosome Breakage in the Fragile X GenomeArijita Chakraborty, Piroon Jenjaroenpun, Jing Li, et al.
Angewandte Chemie (International Ed. in English)|December 24, 2024
Probing the Protein Kinases' Cysteinome by Covalent FragmentsGuiqun Wang, Nico J Seidler, Sandra Röhm, et al.
Cancer Discovery|December 1, 2022
Mutant NPM1 Directly Regulates Oncogenic Transcription in Acute Myeloid LeukemiaHannah J Uckelmann, Elena L Haarer, Reina Takeda, et al.
Nature Communications|July 22, 2018
TIGIT<sup>+</sup> iTregs elicited by human regulatory macrophages control T cell immunityPaloma Riquelme, Jan Haarer, Anja Kammler, et al.
Molecular Cancer Research : MCR|March 20, 2021
EWS-FLI1 and Menin Converge to Regulate ATF4 Activity in Ewing SarcomaJennifer A Jiménez, April A Apfelbaum, Allegra G Hawkins, et al.
Communications Biology|October 24, 2023
SaLT&PepPr is an interface-predicting language model for designing peptide-guided protein degradersGaryk Brixi, Tianzheng Ye, Lauren Hong, et al.
Chemical Biology & Drug Design|June 22, 2007
Structure-based drug design of pyrrolidine-1, 2-dicarboxamides as a novel series of orally bioavailable factor Xa inhibitorsChad A Van Huis, Christopher F Bigge, Agustin Casimiro-Garcia, et al.
Bioorganic & Medicinal Chemistry|March 15, 2006
The discovery of glycine and related amino acid-based factor Xa inhibitorsJeffrey T Kohrt, Kevin J Filipski, Wayne L Cody, et al.
Chemical Biology & Drug Design|August 9, 2007
The discovery of (2R,4R)-N-(4-chlorophenyl)-N- (2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidine-1,2-dicarboxamide (PD 0348292), an orally efficacious factor Xa inhibitorJeffrey T Kohrt, Christopher F Bigge, John W Bryant, et al.
Medrxiv : the Preprint Server for Health Sciences|January 14, 2021
Increased Risk of Autopsy-Proven Pneumonia with Sex, Season and Neurodegenerative DiseaseThomas G Beach, Aryck Russell, Lucia I Sue, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Cell Reports|September 23, 2020
Replication Stress Induces Global Chromosome Breakage in the Fragile X GenomeArijita Chakraborty, Piroon Jenjaroenpun, Jing Li, et al.
Angewandte Chemie (International Ed. in English)|December 24, 2024
Probing the Protein Kinases' Cysteinome by Covalent FragmentsGuiqun Wang, Nico J Seidler, Sandra Röhm, et al.
Cancer Discovery|December 1, 2022
Mutant NPM1 Directly Regulates Oncogenic Transcription in Acute Myeloid LeukemiaHannah J Uckelmann, Elena L Haarer, Reina Takeda, et al.
Nature Communications|July 22, 2018
TIGIT<sup>+</sup> iTregs elicited by human regulatory macrophages control T cell immunityPaloma Riquelme, Jan Haarer, Anja Kammler, et al.
Molecular Cancer Research : MCR|March 20, 2021
EWS-FLI1 and Menin Converge to Regulate ATF4 Activity in Ewing SarcomaJennifer A Jiménez, April A Apfelbaum, Allegra G Hawkins, et al.
Communications Biology|October 24, 2023
SaLT&PepPr is an interface-predicting language model for designing peptide-guided protein degradersGaryk Brixi, Tianzheng Ye, Lauren Hong, et al.
Chemical Biology & Drug Design|June 22, 2007
Structure-based drug design of pyrrolidine-1, 2-dicarboxamides as a novel series of orally bioavailable factor Xa inhibitorsChad A Van Huis, Christopher F Bigge, Agustin Casimiro-Garcia, et al.
Bioorganic & Medicinal Chemistry|March 15, 2006
The discovery of glycine and related amino acid-based factor Xa inhibitorsJeffrey T Kohrt, Kevin J Filipski, Wayne L Cody, et al.
Chemical Biology & Drug Design|August 9, 2007
The discovery of (2R,4R)-N-(4-chlorophenyl)-N- (2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidine-1,2-dicarboxamide (PD 0348292), an orally efficacious factor Xa inhibitorJeffrey T Kohrt, Christopher F Bigge, John W Bryant, et al.
Medrxiv : the Preprint Server for Health Sciences|January 14, 2021
Increased Risk of Autopsy-Proven Pneumonia with Sex, Season and Neurodegenerative DiseaseThomas G Beach, Aryck Russell, Lucia I Sue, et al.
Pageof 11